Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014 (2014), Article ID 780179, 11 pages
http://dx.doi.org/10.1155/2014/780179
Review Article

Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy

Istituto di Biomedicina ed Immunologia Molecolare (IBIM) “Alberto Monroy,” CNR, via Ugo La Malfa 153, 90146 Palermo, Italy

Received 19 March 2014; Accepted 29 May 2014; Published 20 August 2014

Academic Editor: Giles E. Hardingham

Copyright © 2014 Pasquale Picone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Walsh and D. J. Selkoe, “Aβ oligomers: a decade of discovery,” Journal of Neurochemistry, vol. 101, no. 5, pp. 1172–1184, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. P. I. Moreira, C. Carvalho, X. Zhu, M. A. Smith, and G. Perry, “Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology,” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 2–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. H. Swerdlow, J. M. Burns, and S. M. Khan, “The Alzheimer's disease mitochondrial cascade hypothesis,” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. S265–S279, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. X. Chen and S. S. Yan, “Role of mitochondrial amyloid-beta in Alzheimers disease,” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. S569–S578, 2010. View at Google Scholar
  5. L. Tillement, L. Lecanu, and V. Papadopoulos, “Alzheimer's disease: effects of β-amyloid on mitochondria,” Mitochondrion, vol. 11, no. 1, pp. 13–21, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. I. Moreira, A. I. Duarte, M. S. Santos, A. C. Rego, and C. R. Oliveira, “An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 16, no. 4, pp. 741–761, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. X. H. Zhu, H. Qiao, F. Du et al., “Quantitative imaging of energy expenditure in human brain,” Neuroimage, vol. 60, no. 4, pp. 2107–2117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. T. L. Schwarz, “Mitochondrial trafficking in neurons,” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 6, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. P. Mattson, M. Gleichmann, and A. Cheng, “Mitochondria in neuroplasticity and neurological disorders,” Neuron, vol. 60, no. 5, pp. 748–766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-. Vayssiere, L. Cordeau-Lossouarn, J. C. Larcher, M. Basseville, F. Gros, and B. Croizat, “Participation of the mitochondrial genome in the differentiation of neuroblastoma cells,” In Vitro Cellular and Developmental Biology, vol. 28, no. 11-12, pp. 763–772, 1992. View at Google Scholar · View at Scopus
  11. V. Voccoli and L. Colombaioni, “Mitochondrial remodeling in differentiating neuroblasts,” Brain Research, vol. 1252, pp. 15–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Ruthel and P. J. Hollenbeck, “Response of mitochondrial traffic to axon determination and differential branch growth,” Journal of Neuroscience, vol. 23, no. 24, pp. 8618–8624, 2003. View at Google Scholar · View at Scopus
  13. H. Kondoh, M. E. Lleonart, D. Bernard, and J. Gil, “Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization,” Histology and Histopathology, vol. 22, no. 1–3, pp. 85–90, 2007. View at Google Scholar · View at Scopus
  14. Y. Wang, N. Mah, A. Prigione, K. Wolfrum, M. A. Andrade-Navarro, and J. Adjaye, “A transcriptional roadmap to the induction of pluripotency in somatic cells,” Stem Cell Reviews and Reports, vol. 6, no. 2, pp. 282–296, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Hardy, “Amyloid, the presenilins and Alzheimer's disease,” Trends in Neurosciences, vol. 20, no. 4, pp. 154–159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. M. P. Mattson, “Cellular action sofbeta-amyloid precursor protein and its soluble and fibrillogenic derivative,” Physiological Reviews, vol. 77, pp. 1081–1132, 1997. View at Google Scholar
  17. S. Lammich, E. Kojro, R. Postina et al., “Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 7, pp. 3922–3927, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. M. O. Grimm, I. Tomic, and T. Hartmann, “Potential external source of Aβ in biological samples,” Nature Cell Biology, vol. 4, pp. E164–E165, 2002. View at Publisher · View at Google Scholar
  19. S. S. Sisodia and P. H. St George-Hyslop, “γ-secretase, Notch, Aβ and Alzheimer's disease: where do the presenilins fit in?” Nature Reviews Neuroscience, vol. 3, no. 4, pp. 281–290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. B. de Strooper, “Aph-1, Pen-2, and Nicastrin with Presenilin generate an active γ-Secretase complex,” Neuron, vol. 38, no. 1, pp. 9–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Steiner, R. Fluhrer, and C. Haass, “Intramembrane proteolysis by γ-secretase,” The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29627–29631, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Haass, M. G. Schlossmacher, A. Y. Hung et al., “Amyloid β-peptide is produced by cultured cells during normal metabolism,” Nature, vol. 359, no. 6393, pp. 322–325, 1992. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Haass, A. Y. Hung, M. G. Schlossmacher, D. B. Teplow, and D. J. Selkoe, “β-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms,” The Journal of Biological Chemistry, vol. 268, no. 5, pp. 3021–3024, 1993. View at Google Scholar · View at Scopus
  24. B. Grziwa, M. O. W. Grimm, C. L. Masters, K. Beyreuther, T. Hartmann, and S. F. Lichtenthaler, “The transmembrane domain of the amyloid precursor protein in microsomal membranes is on both sides shorter than predicted,” Journal of Biological Chemistry, vol. 278, no. 9, pp. 6803–6808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Duering, M. O. W. Grimm, H. S. Grimm, J. Schröder, and T. Hartmann, “Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42,” Neurobiology of Aging, vol. 26, no. 6, pp. 785–788, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. R. W. Choy, Z. Cheng, and R. Schekman, “Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 30, pp. E2077–E2082, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Y. Cha, S. H. Han, S. M. Son et al., “Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death,” PLoS ONE, vol. 7, no. 4, Article ID e34929, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. X. Chen and S. D. Yan, “Amyloid-β-induced mitochondrial dysfunction,” Journal of Alzheimer's Disease, vol. 12, no. 2, pp. 177–184, 2007. View at Google Scholar · View at Scopus
  29. C. Caspersen, N. Wang, J. Yao et al., “Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease,” The FASEB Journal, vol. 19, no. 14, pp. 2040–2041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zhang, Y. Zhang, Y. Chen et al., “Appoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration,” Journal of Neuroscience, vol. 32, no. 44, pp. 15565–15576, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. H. K. Anandatheerthavarada, G. Biswas, M. Robin, and N. G. Avadhani, “Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells,” Journal of Cell Biology, vol. 161, no. 1, pp. 41–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Devi, B. M. Prabhu, D. F. Galati, N. G. Avadhani, and H. K. Anandatheerthavarada, “Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction,” Journal of Neuroscience, vol. 26, no. 35, pp. 9057–9068, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Hansson Petersen, N. Alikhani, H. Behbahani et al., “The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 35, pp. 13145–13150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Tillement, L. Lecanu, W. Yao, J. Greeson, and V. Papadopoulos, “The spirostenol (22R, 25R)-20α-spirost-5-en-3β-yl hexanoate blocks mitochondrial uptake of Aβ in neuronal cells and prevents Aβ-induced impairment of mitochondrial function,” Steroids, vol. 71, no. 8, pp. 725–735, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. K. C. Walls, P. Coskun, J. L. Gallegos-Perez et al., “Swedish Alzheimer mutation induces mitochondrial dysfunction mediated by HSP60 mislocalization of amyloid precursor protein (APP) and β-amyloid,” The Journal of Biological Chemistry, vol. 287, no. 36, pp. 30317–30327, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Picone, M. L. Bondi, G. Montana et al., “Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: improved delivery by solid lipid nanoparticles,” Free Radical Research, vol. 43, no. 11, pp. 1133–1145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Picone, R. Carrotta, G. Montana, M. R. Nobile, P. L. San Biagio, and M. Di Carlo, “Aβ oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures,” Biophysical Journal, vol. 96, no. 10, pp. 4200–4211, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Di Carlo, D. Giacomazza, P. Picone, D. Nuzzo, and P. L. San Biagio, “Are oxidative stress and mitochondrial dysfunction the key players in the neurodegenerative diseases?” Free Radical Research, vol. 46, no. 11, pp. 1327–1338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Picone, D. Nuzzo, and M. Di Carlo, “Ferulic acid: a natural antioxidant against oxidative stress induced by oligomeric A-beta on sea urchin embryo,” Biological Bulletin, vol. 224, no. 1, pp. 18–28, 2013. View at Google Scholar · View at Scopus
  40. N. Dragicevic, M. Mamcarz, Y. Zhu et al., “Mitochondrial amyloid-β levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice,” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. S535–S550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Xie, J. Guan, L. A. Borrelli, J. Xu, A. Serrano-Pozo, and B. J. Bacskai, “Mitochondrial alterations near amyloid plaques in an alzheimer's disease mouse model,” The Journal of Neuroscience, vol. 33, no. 43, pp. 17042–17051, 2013. View at Publisher · View at Google Scholar
  42. E. Tamagno, M. Parola, P. Bardini et al., “β-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways,” Journal of Neurochemistry, vol. 92, no. 3, pp. 628–636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. M. A. Lovell, S. Xiong, C. Xie, P. Davies, and W. R. Markesbery, “Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3,” Journal of Alzheimer's Disease, vol. 6, no. 6, pp. 659–671, 2004. View at Google Scholar · View at Scopus
  44. R. Sultana, D. Boyd-Kimball, H. F. Poon et al., “Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: a redox proteomics analysis,” Neurobiology of Aging, vol. 27, no. 7, pp. 918–925, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Pastorino, A. Sun, P. J. Lu et al., “The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production,” Nature, vol. 440, no. 7083, pp. 528–534, 2006. View at Publisher · View at Google Scholar
  46. Y. Liou, A. Sun, A. Ryo et al., “Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration,” Nature, vol. 424, no. 6948, pp. 556–561, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Rizzuto, P. Pinton, W. Carrington et al., “Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses,” Science, vol. 280, no. 5370, pp. 1763–1766, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Raturi and T. Simmen, “Where the endoplasmic reticulum and the mitochondrion tie the knot: the mitochondria-associated membrane (MAM),” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1833, no. 1, pp. 213–224, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. A. R. van Vliet, T. Verfaillie, and P. Agostinis, “New functions of mitochondria associated membranes in cellular signaling,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1843, no. 10, pp. 2253–2262, 2014. View at Publisher · View at Google Scholar
  50. E. Area-Gomez, M. Del Carmen Lara Castillo, M. D. Tambini et al., “Upregulated function of mitochondria-associated ER membranes in Alzheimer disease,” EMBO Journal, vol. 31, no. 21, pp. 4106–4123, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. E. A. Schon and E. Area-Gomez, “Is Alzheimer's disease a disorder of mitochondria-associated membranes?” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. S281–S292, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. E. A. Schon and E. Area-Gomez, “Mitochondria-associated ER membranes in Alzheimer disease,” Molecular and Cellular Neuroscience, vol. 55, pp. 26–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Hedskog, C. M. Pinho, R. Filadi et al., “Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 19, pp. 7916–7921, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Krako, M. C. Magnifico, M. Arese et al., “Characterization of mitochondrial dysfunction in the 7PA2 cell model of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 37, no. 4, pp. 747–758, 2013. View at Google Scholar
  55. I. Ferrer, “Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 5, pp. 425–431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. R. G. Cutler, J. Kelly, K. Storie et al., “Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 7, pp. 2070–2075, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. P. J. Crouch, S. M. E. Harding, A. R. White, J. Camakaris, A. I. Bushd, and C. L. Masters, “Mechanisms of Ab mediated neurodegeneration in Alzheimer’s disease,” International Journal of Biochemistry & Cell Biology, vol. 40, pp. 181–198, 2008. View at Google Scholar
  58. V. Chauhan and A. Chauhan, “Oxidative stress in Alzheimer's disease,” Pathophysiology, vol. 13, no. 3, pp. 195–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. H. Fukui and C. T. Moraes, “The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?” Trends in Neurosciences, vol. 31, no. 5, pp. 251–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Yao, R. W. Irwin, L. Zhao, J. Nilsen, R. T. Hamilton, and R. D. Brinton, “Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 34, pp. 14670–14675, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Chua, M. Lim, and B. Wong, “The Kunitz-protease inhibitor domain in amyloid precursor protein reduces cellular mitochondrial enzymes expression and function,” Biochemical and Biophysical Research Communications, vol. 437, no. 4, pp. 642–647, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Sheng, X. Wang, B. Su et al., “Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease,” Journal of Neurochemistry, vol. 120, no. 3, pp. 419–429, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Amiri and P. J. Hollenbeck, “Mitochondrial biogenesis in the axons of vertebrate peripheral neurons,” Developmental Neurobiology, vol. 68, no. 11, pp. 1348–1361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. X. Liu, D. Weaver, O. Shirihai, and G. Hajnóczky, “Mitochondrial kiss-and-run: Interplay between mitochondrial motility and fusion-fission dynamics,” EMBO Journal, vol. 28, no. 20, pp. 3074–3089, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Chen, S. A. Detmer, A. J. Ewald, E. E. Griffin, S. E. Fraser, and D. C. Chan, “Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development,” Journal of Cell Biology, vol. 160, no. 2, pp. 189–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. X. Wang, B. Su, S. L. Siedlak et al., “Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19318–19323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Wang, B. Su, H. Fujioka, and X. Zhu, “Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients,” The American Journal of Pathology, vol. 173, no. 2, pp. 470–482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Manczak and P. H. Reddy, “Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: Implications for mitochondrial dysfunction and neuronal damage,” Human Molecular Genetics, vol. 21, no. 11, pp. 2538–2547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. X. Wang, B. Su, H. Lee et al., “Impaired balance of mitochondrial fission and fusion in Alzheimer's disease,” Journal of Neuroscience, vol. 29, no. 28, pp. 9090–9103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Manczak, M. J. Calkins, and P. H. Reddy, “Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage,” Human Molecular Genetics, vol. 20, no. 13, pp. 2495–2509, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. X. Wang, B. Su, S. L. Siedlak et al., “Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 49, pp. 19318–19323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Tsujimoto and S. Shimizu, “Role of the mitochondrial membrane permeability transition in cell death,” Apoptosis, vol. 12, no. 5, pp. 835–840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. H. Du and S. S. Yan, “Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1802, no. 1, pp. 198–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. V. K. Rao, E. A. Carlson, and S. S. Yan, “Mitochondrial permeability transition pore is a potential drug target for neurodegeneration,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 8, pp. 1267–1272, 2014. View at Publisher · View at Google Scholar
  75. J. W. Lustbader, M. Cirilli, C. Lin et al., “ABAD Directly Links Aβ to Mitochondrial Toxicity in Alzheimer's Disease,” Science, vol. 304, no. 5669, pp. 448–452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Hardy, “Amyloid, the presenilins and Alzheimer's disease,” Trends in Neurosciences, vol. 20, no. 4, pp. 154–159, 1997. View at Publisher · View at Google Scholar · View at Scopus
  77. Y. Yan, Y. Liu, M. Sorci et al., “Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Aβ interaction,” Biochemistry, vol. 46, no. 7, pp. 1724–1731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Yao, H. Du, and S. Yan, “Inhibition of amyloid-β (Aβ) peptide-binding alcohol dehydrogenase-Aβ interaction reduces Aβ accumulation and improves mitochondrial function in a mouse model of alzheimer's disease,” The Journal of Neuroscience, vol. 31, no. 6, pp. 2313–2320, 2011. View at Google Scholar
  79. Y. Ren, W. X. Hong, F. Davey et al., “Endophilin I expression is increased in the brains of Alzheimer disease patients,” The Journal of Biological Chemistry, vol. 283, no. 9, pp. 5685–5691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Yao, M. Taylor, F. Davey et al., “Interaction of amyloid binding alcohol dehydrogenase/Aβ mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model,” Molecular and Cellular Neuroscience, vol. 35, no. 2, pp. 377–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. A. R. Ramjaun, A. Angers, V. Legendre-Guillemin, X. Tong, and P. S. McPherson, “Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase,” Journal of Biological Chemistry, vol. 276, no. 31, pp. 28913–28919, 2001. View at Publisher · View at Google Scholar · View at Scopus
  82. A. Colombo, A. Bastone, C. Ploia et al., “JNK regulates APP cleavage and degradation in a model of Alzheimer's disease,” Neurobiology of Disease, vol. 33, no. 3, pp. 518–525, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. A. Falkevall, N. Alikhani, S. Bhushan et al., “Degradation of the amyloid β-protein by the novel mitochondrial peptidasome, PreP,” Journal of Biological Chemistry, vol. 281, no. 39, pp. 29096–29104, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. N. Alikhani, M. Ankarcrona, and E. Glaser, “Mitochondria and Alzheimer's disease: amyloid-β peptide uptake and degradation by the presequence protease, hPreP,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 5, pp. 447–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. N. Alikhani, L. Guo, S. Yan et al., “Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria,” Journal of Alzheimer's Disease, vol. 27, no. 1, pp. 75–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Filipe Teixeira, C. Moreira Pinho, R. M. Branca, J. Lehtiö, R. L. Levine, and E. Glaser, “In vitro oxidative inactivation of human presequence protease (hPreP),” Free Radical Biology and Medicine, vol. 53, no. 11, pp. 2188–2195, 2012. View at Publisher · View at Google Scholar · View at Scopus
  87. C. Schmidt, E. Lepsverdize, S. L. Chi et al., “Amyloid precursor protein and amyloid β-peptide bind to ATP synthase and regulate its activity at the surface of neural cells,” Molecular Psychiatry, vol. 13, no. 10, pp. 953–969, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Hauptmann, I. Scherping, S. Dröse et al., “Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice,” Neurobiology of Aging, vol. 30, no. 10, pp. 1574–1586, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. V. Rhein, G. Baysang, S. Rao et al., “Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells,” Cellular and Molecular Neurobiology, vol. 29, no. 6-7, pp. 1063–1071, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. A. Bobba, G. Amadoro, D. Valenti, V. Corsetti, R. Lassandro, and A. Atlante, “Mitochondrial respiratory chain Complexes I and IV are impaired by β-amyloid via direct interaction and through Complex I-dependent ROS production, respectively,” Mitochondrion, vol. 13, no. 4, pp. 298–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. D. Praticò, “Oxidative stress hypothesis in Alzheimer's disease: a reappraisal,” Trends in Pharmacological Sciences, vol. 29, no. 12, pp. 609–615, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. R. K. Chaturvedi and M. F. Beal, “Mitochondrial approaches for neuroprotection,” Annals of the New York Academy of Sciences, vol. 1147, pp. 395–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. R. A. J. Smith, V. J. Adlam, F. H. Blaikie et al., “Mitochondria-targeted antioxidants in the treatment of disease,” Annals of the New York Academy of Sciences, vol. 1147, pp. 105–111, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. D. Pratico, “Evidence of oxidative stress in Alzheimers disease brain and antioxidant therapy: lights and shadows,” Annals of the New York Academy of Sciences, vol. 1147, pp. 70–78, 2008. View at Publisher · View at Google Scholar
  95. H. H. Szeto, “Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases,” Annals of the New York Academy of Sciences, vol. 1147, pp. 112–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. M. Manczak, P. Mao, M. J. Calkins et al., “Mitochondria-targeted antioxidants protect against amyloid-β toxicity in Alzheimer's disease neurons,” Journal of Alzheimer's Disease, vol. 20, no. 2, pp. S609–S631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. P. H. Reddy, R. Tripathi, Q. Troung et al., “Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics,” Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1822, no. 5, pp. 639–649, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. J. S. Tauskela, “MitoQ—a mitochondria-targeted antioxidant,” IDrugs, vol. 10, no. 6, pp. 399–412, 2007. View at Google Scholar · View at Scopus
  99. M. F. Ross, T. A. Prime, I. Abakumova et al., “Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells,” Biochemical Journal, vol. 411, no. 3, pp. 633–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. A. Azzi, “Oxidative stress: a dead end or a laboratory hypothesis?” Biochemical and Biophysical Research Communications, vol. 362, no. 2, pp. 230–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. X. Gan, S. Huang, L. Wu et al., “Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1842, no. 2, pp. 220–231, 2014. View at Publisher · View at Google Scholar
  102. Y. Zhao and B. Zhao, “Natural antioxidants in prevention and management of Alzheimer's disease,” Frontiers in Bioscience (Elite edition), vol. 4, pp. 794–808, 2012. View at Google Scholar · View at Scopus
  103. G. P. Lim, T. Chu, F. Yang, W. Beech, S. A. Frautschy, and G. M. Cole, “The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse,” Journal of Neuroscience, vol. 21, no. 21, pp. 8370–8377, 2001. View at Google Scholar · View at Scopus
  104. S. A. Frautschy, W. Hu, P. Kim et al., “Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology,” Neurobiology of Aging, vol. 22, no. 6, pp. 993–1005, 2001. View at Publisher · View at Google Scholar · View at Scopus
  105. F. Yang, G. P. Lim, A. N. Begum et al., “Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo,” The Journal of Biological Chemistry, vol. 280, no. 7, pp. 5892–5901, 2005. View at Publisher · View at Google Scholar · View at Scopus
  106. L. Baum, C. W. K. Lam, S. K. Cheung et al., “Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease,” Journal of Clinical Psychopharmacology, vol. 28, no. 1, pp. 110–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. S. Marrache and S. Dhar, “Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 40, pp. 16288–16293, 2012. View at Publisher · View at Google Scholar · View at Scopus
  108. R. Abdel-Kader, S. Hauptmann, U. Keil et al., “Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761),” Pharmacological Research, vol. 56, no. 6, pp. 493–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  109. V. Rhein, M. Giese, G. Baysang et al., “Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues Aβ-induced failure,” PLoS ONE, vol. 5, no. 8, Article ID e12359, 2010. View at Publisher · View at Google Scholar · View at Scopus